THIS WEBSITE IS FOR HEALTHCARE PROFESSIONALS ONLY
This website contains promotional information on Defitelio▼ (defibrotide) and has been developed in-line with EU marketing authorisation. Please consult local prescribing information for further information.
By entering this site, you are confirming that you are a healthcare professional within your selected country.
Adverse events should be reported. Healthcare professionals are asked to report any adverse events via their national reporting system (see Section 4.8 of SmPC). Adverse events should also be reported to Jazz Pharmaceuticals by email to medinfo-int@jazzpharma.com or phone via +353 1 968 1631 (may include an international call charge).
▼ - This medicinal product is subject to additional monitoring